Username
Oncology
Early Phase / Multiple Disease Site
Hematologic Malignancies
Early Phase Team
Lymphoma
NHL
Follicular
Relapsed/Refractory
2 or more prior lines
menu
Search
Should appear
Must not appear
Categories
Search
Protocols
show categories
Search
TENEOBIO-TENEOTWO-TNB486-001
Phase I
OPEN TO ACCRUAL
A Multicenter, Phase 1, Open-Label, Dose-Escalation and Expansion Study of TNB-486, a Bispecific Antibody Targeting CD19 in Subjects with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Search